Molecular targets and biological modifiers in gastric cancer

被引：35
|
作者：
Carneiro, Fatima [1 ,2 ,3 ]
Oliveira, Carla [1 ,2 ]
Leite, Marina [1 ]
Seruca, Raquel [1 ,2 ]
机构：
[1] Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal
[2] Univ Porto, Fac Med, P-4100 Oporto, Portugal
[3] Hosp Sao Joao, Dept Pathol, Oporto, Portugal
来源：
SEMINARS IN DIAGNOSTIC PATHOLOGY | 2008年 / 25卷 / 04期
关键词：
Gastric cancer; Molecular targets; Mutation; E-cadherin (CDHI); Microsatellite instability;
D O I：
10.1053/j.semdp.2008.07.004
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
The overall survival of gastric cancer patients remains poor despite efforts and advances in its prevention, diaposis, and treatment. The development of new therapies is crucial for the effective control of this disease. An increasing number of genetic and epigenetic alterations have been associated with distinct histological types of gastric cancer. In this review, we will discuss the involvement of E-cadherin, EGFR, ERBB2, MMR genes, KRAS, and PIK3CA in the development and progression of gastric cancer and their role as biomarkers or as novel putative targets for therapy. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码：274 / 287
页数：14
相关论文
共 50 条
  • [21] New targets in gastric cancer
    Volkov N.M.
    memo - Magazine of European Medical Oncology, 2015, 8 (2) : 92 - 100
  • [22] Novel molecular targets in gastric adenocarcinoma
    Ramezankhani, Roya
    Solhi, Roya
    Es, Hamidreza Aboulkheyr
    Vosough, Massoud
    Hassan, Moustapha
    PHARMACOLOGY & THERAPEUTICS, 2021, 220
  • [23] Molecular mechanism and potential therapeutic targets of liver metastasis from gastric cancer
    Li, Difeng
    Zhang, Xin
    Jiang, Lili
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [24] Inhibitory effects of curcumin on gastric cancer cells: A proteomic study of molecular targets
    Cai, X. Z.
    Huang, W. Y.
    Qiao, Y.
    Du, S. Y.
    Chen, Y.
    Chen, D.
    Yu, S.
    Che, R. C.
    Liu, N.
    Jiang, Y.
    PHYTOMEDICINE, 2013, 20 (06) : 495 - 505
  • [25] Quantitative proteomic profiling of potential molecular targets for multidrug resistance in gastric cancer
    Cai, Xiqiang
    Yin, Fang
    Hu, Sijun
    Zhang, Cui
    Chen, Ruirui
    Xiao, Xiao
    Wu, Kaichun
    Nie, Yongzhan
    Fan, Daiming
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 449 - 449
  • [26] Sex differences in the clinicopathological and molecular biological features of gastric cancer.
    Terashima, Masanori
    Yagi, Taisuke
    Hatakeyama, Keiichi
    Furukawa, Kenichiro
    Fujiya, Keiichi
    Tanizawa, Yutaka
    Bando, Etsuro
    Yamaguchi, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 421 - 421
  • [27] GASTRIC CANCER BIOLOGICAL BEHAVIOUR: FROM BIOINFORMATIC HYPOTHESIS TO MOLECULAR ANALYSIS
    Compare, D.
    Rocco, A.
    Liguori, E.
    Cianflone, A.
    Amato, R.
    Monticelli, A.
    Miele, G.
    Cocozza, S.
    Nardone, G.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S138 - S138
  • [28] COMBINING CHEMOTHERAPY WITH BIOLOGICAL RESPONSE MODIFIERS IN TREATMENT OF CANCER
    MITCHELL, MS
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (18) : 1445 - 1450
  • [29] BIOLOGICAL RESPONSE MODIFIERS PROVING EFFECTIVE IN TREATING CANCER
    RAWLS, RL
    CHEMICAL & ENGINEERING NEWS, 1985, 63 (24) : 10 - 16
  • [30] THERAPY OF PERITONEAL MURINE CANCER WITH BIOLOGICAL RESPONSE MODIFIERS
    SALUP, RR
    HERBERMAN, RB
    CHIRIGOS, MA
    BACK, T
    WILTROUT, RH
    JOURNAL OF IMMUNOPHARMACOLOGY, 1985, 7 (04): : 417 - 436
12345